Products
Online Inquiry
(20R)-Protopanaxadiol
Cat. No.:
0225LY-1303
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
(20R)-Protopanaxadiol exhibits anti-tumor properties by enhancing host immunity, increasing NK cell activity and IL-2 levels while reducing tumor microvascular density; additionally, it helps mitigate hypertriglyceridemia, fatty liver, and obesity in high-fat diet models.
Synonym:
Protopanaxadiol; 20R-Protopanaxadiol; (20R)-Protopanaxdiol; 7755-01-3; Protopanaxadiol; 20(R)Protopanaxdiol; (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol; 24-Dammarene-3beta,12beta-20S-triol
CAS No.:
7755-01-3
Compound CID:
9920281
Formula:
C30H52O3
Formula Weight:
460.73
Specification
Relative Density:
1.036 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
(20R)-Protopanaxadiol can be used in molecular oncology to examine the induction of apoptosis and the regulation of metabolic pathways in malignant cells.
Library Information
Target:
Cell wall synthesis
Receptor:
PBPs
Pathways:
Microbiology/Virology
Plate Number:
AOCL-17
Plate Location:
f10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
10 mg/mL; 21.7 mM
Solubility:
Soluble in chloroform, dichloromethane, ethyl acetate, acetone, etc.
